uniQure NV
(LTS:0EE0)
$
42.9
+1.745 (+4.24%)
Market Cap: 2.99 Bil
Enterprise Value: 2.47 Bil
PE Ratio: 0
PB Ratio: 18.35
GF Score: 47/100 Uniqure NV at RBC Capital Markets Global Healthcare Conference Transcript
May 19, 2026 / 03:30PM GMT
Release Date Price:
$24.82
(-0.92%)
Luca Issi
RBC Capital Markets Inc - Analyst
Oh, great. Thanks. Hello, everybody. Luca AC, Senior Biotech Analyst here at RBC Capital Market. And today is our great privilege to have Unicure as part of the 2026 Global Healthcare Conference. Representing the company, we have Matt Kapusta, Chief Executive Officer. Matt, thanks so much for joining us. How are you doing today?
Matthew Kapusta
Uniqure NV - Chief Executive Officer, Executive Director
Doing great. Thanks for having us, Luca.
Questions & Answers
Luca Issi
RBC Capital Markets Inc - Analyst
Great. Great. We have a very long list of questions here, Matt. But maybe before we go into the specifics, you'll be fantastic if you can start maybe a little bit high-level. Maybe give us a few of the highlights of what progress has the organization made over the last few months and most importantly, what's ahead here for Unicure?
Matthew Kapusta
Uniqure NV - Chief Executive Officer, Executive Director
Yeah, so we
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot